Evidence map›Paper›PMID 19955368›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2009

The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors.

Benjamin Kefas, Laurey Comeau, Desiree H Floyd, Oleksandr Seleverstov, Jakub Godlewski, Tom Schmittgen, Jinmai Jiang, Charles G diPierro, Yunqing Li, E Antonio Chiocca and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Benjamin KefasDivision of Neuro-Oncology, Neurology Department, University of Virginia Health System, Charlottesville, Virginia 22908, USA.
Laurey Comeau
Desiree H Floyd
Oleksandr Seleverstov
Jakub Godlewski
Tom Schmittgen
Jinmai Jiang
Charles G diPierro
Yunqing Li
E Antonio Chiocca
Jeongwu Lee
Howard Fine
Roger Abounader
Sean Lawler
Benjamin Purow
The Ohio State University · USUniversity of Virginia · USUniversity of Virginia Health System · USKennedy Krieger Institute · USNational Institute of Neurological Disorders and Stroke · USNational Institutes of Health · US

Funding

Investigation of Notch-inhibiting microRNAs in gliomaR01CA136803 · NCI · UNIVERSITY OF VIRGINIA · PI PUROW, BENJAMIN W. · 2009 to 2013
$1.5M
VIRAL GENE FUNCTIONS INVOLVED IN TRANSFORMATIONR01CA013608 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI VOGT, MARGUERITE M · 1985 to 1995
–
NCI NIH HHS R01CA1360803NCI NIH HHS R01 CA136803
6 · The paper itself

Abstract

Little is known of microRNA interactions with cellular pathways. Few reports have associated microRNAs with the Notch pathway, which plays key roles in nervous system development and in brain tumors. We previously implicated the Notch pathway in gliomas, the most common and aggressive brain tumors. While investigating Notch mediators, we noted microRNA-326 was upregulated following Notch-1 knockdown. This neuronally expressed microRNA was not only suppressed by Notch but also inhibited Notch proteins and activity, indicating a feedback loop. MicroRNA-326 was downregulated in gliomas via decreased expression of its host gene. Transfection of microRNA-326 into both established and stem cell-like glioma lines was cytotoxic, and rescue was obtained with Notch restoration. Furthermore, miR-326 transfection reduced glioma cell tumorigenicity in vivo. Additionally, we found microRNA-326 partially mediated the toxic effects of Notch knockdown. This work demonstrates a microRNA-326/Notch axis, shedding light on the biology of Notch and suggesting microRNA-326 delivery as a therapy.

Indexed as

ApoptosisArrestinsbeta-ArrestinsBrain NeoplasmsCell Line, TumorCell ProliferationFlow CytometryGene Expression ProfilingGene Expression Regulation, NeoplasticGliomaHumansMicroRNAsNeoplastic Stem CellsOligonucleotide Array Sequence AnalysisReceptor, Notch1RNA, Small InterferingArrestinsbeta-ArrestinsMicroRNAsMIRN326 microRNA, humanNOTCH1 protein, humanReceptor, Notch1RNA, Small Interfering

Identifiers

PMID19955368
PMCPMC2823067
OpenAlexW2012014035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.